REPORTS of brain swelling have thrown the safety of Alzheimer's drug Aduhelm into question after the concerning side effect was observed in 41 percent of patients taking the recommended dose. The new findings are being investigated by the FDA.
You Can See More: Alzheimer's disease: Concerns over new drug after brain swelling found in 41% of patients
The following article Alzheimer's disease: Concerns over new drug after brain swelling found in 41% of patients is courtesy of Daily Express :: Health Feed
REPORTS of brain swelling have thrown the safety of Alzheimer's drug Aduhelm into question after the concerning side effect was observed in 41 percent of patients taking the recommended dose. The new findings are being investigated by the FDA.
REPORTS of brain swelling have thrown the safety of Alzheimer's drug Aduhelm into question after the concerning side effect was observed in 41 percent of patients taking the recommended dose. The new findings are being investigated by the FDA.
Related Posts:
You Can See More: Coronavirus - the tropical fruit to boost the immune system and protect against COVID-19- You Can See More: Coronavirus update symptoms: Experts discusses anosmia – what it is and how to diagnose
- You Can See More: How to sleep: Inhale this sweet-smelling fragrance before bed to promote sleep
- You Can See More: How to help anxiety: Three herbal supplements proven to alleviate anxiety
- You Can See More: Pollen count: Wearing this on your face may reduce hay fever symptoms if the count is high
0 comments:
Post a Comment
Note: Only a member of this blog may post a comment.